$CALC

Middleton Fred A purchased $200K of CALC (indirect holdings)

Middleton Fred A purchased 248,972 indirectly-held shares of CalciMedica, Inc. (CALC) at $0.80 ($0.20M total) on 2026-06-25.

Original reporting
SEC EDGAR · Middleton Fred A
Published Jun 29, 2026, 12:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 29, 2026, 1:06 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$CALC
Bullish
low confidence
Mentioned
$CALC
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CALCBullishLow
01

Why it matters

The newest fact is the disclosed open-market purchase amount, price, and post-transaction holdings by a director/10% owner.

02

Market read

Traders may treat the filing as a small sentiment input, but it does not replace fundamental catalysts.

03

What to watch

No 10b5-1 plan is cited, but the article also lacks context on prior insider activity, total position changes over time, and whether the company has concurrent catalysts (financing, trial updates, or contracts).

Relevance 5/10Novelty 6/10Timing: new Form 4 filed 2026-06-29 (transaction dated 2026-06-25)

Background

The article is an SEC Form 4 insider transaction disclosure for CalciMedica, Inc.

Company-level read

Ticker impact

$CALCBullishLow confidence
Context

SEC Form 4 shows director/10% owner Middleton Fred A bought 248,972 shares of CalciMedica at $0.8033 on 2026-06-25.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and small unless follow-on buying or other disclosures appear.

Evidence & confidence

The filing is primary-source and specific, but the article provides no new company fundamentals beyond the transaction details and the size is not tied to a broader corporate event.

Market effects

No sector-level read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

The purchase is indirect and under a 10% owner/director role; it may reflect liquidity planning or pre-existing arrangements rather than a strong valuation signal.

Key entities

  • CalciMedica, Inc.

    Subject of the Form 4 insider transaction; ticker CALC.

  • Middleton Fred A

    Director and 10% owner who purchased shares indirectly.

Related articles